Navigation Links
FDA Approves New Dosing for FASLODEX® (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
Date:9/10/2010

arter 2010. During this time, FASLODEX 250mg will still be available.

According to data from the U.S. National Cancer Institute, more than 207,000 American women will be diagnosed with breast cancer in 2010.(3) Approximately 155,000 women in the United States are currently living with metastatic breast cancer, and this number is projected to increase to nearly 162,000 by the year 2011.(4)

The CONFIRM study, presented for the first time at the annual San Antonio Breast Cancer Symposium (SABCS) in December 2009, showed FASLODEX 500mg reduced the risk of disease progression (assessed as progression free survival) by 20 percent (HR 0.80; 95% CI 0.68-0.94, p=0.006) when compared with FASLODEX 250mg. FASLODEX 500mg significantly increased median progression free survival to 6.5 months vs. 5.4 months with 250mg (p=0.006).

Objective Response Rates calculated in patients with measurable disease was not significantly different between FASLODEX 500mg (13.8%) and 250mg (14.6%) (HR=0.94; 95% CI: 0.57-1.55) (p=0.795).  Median overall survival was 25.1 months with FASLODEX 500mg and 22.8 months with 250mg (HR=0.84; 95% CI: 0.69-1.03) (p=0.091).  At the time of analysis, overall survival was not statistically significant. A pre-planned second survival analysis will occur as data mature when approximately 75% of patients have had an event.  

Important Safety Information About FASLODEX® (fulvestrant) Injection

FASLODEX is contraindicated in patients with known hypersensitivity to the drug or to any of its components. Hypersensitivity reactions, including urticaria and angioedema have been reported in association with FASLODEX.

Because FASLODEX is administered intramuscularly, it should be used with caution in patients with bleeding diatheses, thrombocytopenia, or in patients on anticoagulants. FASLODEX is metabolized primarily in the liver. A 250-mg dose is recommended in patients with moderate hepatic impairment. F
'/>"/>

SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Pediatric Use of Chemical Poisoning Treatment
2. FDA Approves Merz Pharmaceuticals Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
3. FDA Approves Vaccines for the 2010-2011 Influenza Season
4. FDA Approves Strativa Pharmaceuticals Zuplenz® (ondansetron) Oral Soluble Film
5. FDA Approves Sagent Pharmaceuticals Heparin Sodium Injection, USP
6. U.S. FDA Approves Improved Performance of Riverain Medicals OnGuard Chest X-ray Computer-Aided Detection Technology
7. FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women
8. FDA Approves New Treatment for Late-Onset Pompe Disease
9. FDA Approves Cefepime for Use In B. Brauns DUPLEX(R) System
10. U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
11. FDA Approves New Combination Product Oral Contraceptive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... -- Legislation passed today by the House Ways and ... inappropriate prescriptions in Medicare Part D from crossing the ... Act (PIMA) of 2014 , introduced by Ways and ... and Ranking Member Jim McDermott (D-WA), recognizes the need ... the right policies, said the Pharmaceutical Care Management Association ...
(Date:2/26/2015)... , February 26, 2015 ... Outlook 2015: First -In- Class Innovations and Cost ... for Large Cap Pharmaceutical Companies research report to ... According to this Global Pharma US & ... as productivity measurements, divestment of non-core assets result ...
(Date:2/26/2015)...  BD Life Sciences, a segment of BD ... ), a leading global medical technology company, and ... high-resolution biology, today announced that they will be ... cell isolation and single-cell gene expression analysis. ... FACS™ single-cell sorting instrumentation and software with Cellular ...
Breaking Medicine Technology:PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 3
... expected by mid-2009 - - Data from second ... ROCKVILLE, Md., Aug. 27 Human Genome,Sciences, Inc. ... enrollment,and initial dosing in BLISS-76, the second of two ... patients with,active systemic lupus erythematosus (SLE). Belimumab is being ...
... can drive safely six weeks following surgical,treatment, ROSEMONT, ... patients, pain levels are so low that they are ... again. A study published in the August,2008 issue of ... ),also found that emergency brake time response in patients ...
Cached Medicine Technology:Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Braking After Bunion Surgery 2Braking After Bunion Surgery 3
(Date:2/28/2015)... With their commitment to achieving physical results and ... to their already robust library of oblique exercises. “Rope ... as, is often performed on a stationary piece of ... relatively safe manner and can be performed by individuals ... of “Rope Pulls” is located in the oblique exercises ...
(Date:2/28/2015)... 2015 March—also known as National ... remind ourselves and others that suspected head injuries, ... Specialists (ANS). , Concussions are a form of ... of TBIs. There are 1.6-3.8 million sports-related concussions ... but it is a brain injury. Many athletes ...
(Date:2/28/2015)... 28, 2015 Indosoft Inc , ... for Asterisk, are pleased to announce the development of ... and 5.8 versions of Q-Suite, this new version will ... number of new features to the leading edge call ... Q-Suite 5.9 will add features to enhance security and ...
(Date:2/28/2015)... The Mesothelioma Applied Research Foundation (Meso ... Symposium on Malignant Mesothelioma on Monday, March 2. The ... Bethesda in Bethesda, Maryland. The following award recipients will ... the mission to cure mesothelioma. , The Klaus Brauch ... Miriam Ratner. Miriam runs the Meso Foundation’s monthly spousal ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Dr. ... Central Coast area residents, recently announced a special offer ... It’s a treatment option for new and established patients ... 2015 with a bright, white smile, Dr. Patel and ... of $299, marked down from the regular price of ...
Breaking Medicine News(10 mins):Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2
... WEDNESDAY, Aug. 3 (HealthDay News) -- Stomach cancer tumors ... treatment, researchers have found. In identifying two distinct ... regimen of chemotherapy is more effective on one tumor ... The study authors said their findings would help doctors ...
... Scientists at Cold Spring Harbor Laboratory (CSHL) and five other ... to identify a new potential treatment for acute myeloid leukemia ... 3, the scientists have pinpointed a protein called Brd4 as ... that is currently incurable in 70% of patients. Using a ...
... 21, 2011 - The University of Rhode Island,s College ... the latest technology, providing instant access to a patient,s ... reduce hospital readmissions. The Center for Technology and ... College of Pharmacy to work collaboratively with the Rhode ...
... New Rochelle, NY, August 3, 2011Positive activity interventions ... to managing depression and may offer hope to ... or have access to adequate medical therapy, according ... Journal of Alternative and Complementary Medicine , a ...
... WEDNESDAY, Aug. 3 (HealthDay News) -- Changes in brain areas ... depressed after they quit smoking, which increases their risk of ... conducted PET brain scans on 24 nonsmokers, 12 moderate smokers ... (25 or more cigarettes a day). The scans revealed ...
... For more than 15 years, Kansas State University researcher ... friend. But there is an interesting twist in ... disease in dogs is similar to the same disease ... friend, too. Further proof of the bond between ...
Cached Medicine News:Health News:Stomach Cancer Tumors Have Genetic Differences: Researchers 2Health News:Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia 2Health News:Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia 3Health News:Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia 4Health News:Home pharmacist visits seek to cut hospital readmission rates 2Health News:Harnessing the power of positive thoughts and emotions to treat depression 2Health News:Smoking Withdrawal Shows Up in Brain Mood Centers 2Health News:A research tale with a heart to match: Professor looks at cardiovascular disease in dogs 2Health News:A research tale with a heart to match: Professor looks at cardiovascular disease in dogs 3
... Microscope Camera from ImagingPlanet Research ... that delivers increased image resolution and ... price. Document, Archive and Publish ... digital microscope camera designed for microscope ...
The ImagingPlanet 70 mm surgical microscope video adapter: Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Leica surgica...
The ImagingPlanet 55 mm surgical microscope video adapter: superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical ...
The ImagingPlanet 80 mm surgical microscope video adapter: superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Leica surgical...
Medicine Products: